Clinical Trials Logo
  1. Home
  2. Eczema
  3. NCT03050151

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

Eczema, Atopic Clinical Trial

Official title:
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis

Clinical Trial Summary

To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).

Clinical Trial Description

Study is conducted in 2 parts: part A and part B.

Part A - Patients with moderate-to-severe AD will be randomized to receive dupilumab (dose 1) by auto-injector (AI) device or prefilled syringe.

Once part A is completely enrolled, part B will randomize patients with moderate-to-severe AD to receive dupilumab (dose 2) by auto-injector (AI) device or prefilled syringe. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03050151
Study type Interventional
Source Regeneron Pharmaceuticals
Contact
Status Completed
Phase Phase 1
Start date February 28, 2017
Completion date February 12, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT03568136 - Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis Phase 2
Recruiting NCT05575882 - Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream Intended for Very Dry, Irritated to Atopic Sensitive Skin. N/A
Completed NCT05003453 - The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema Phase 2/Phase 3
Recruiting NCT06436183 - A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis Phase 2
Recruiting NCT05642208 - Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis Phase 4
Active, not recruiting NCT05913791 - Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema N/A
Completed NCT00560378 - Long-term Safety of Protopic in Atopic Eczema Phase 3
Terminated NCT00671528 - Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) Phase 4
Terminated NCT05732454 - A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection Phase 2/Phase 3
Completed NCT03175354 - A Study in Subjects With Moderate Atopic Dermatitis Phase 2